S-Curis

Sejong City, South Korea Founded: 2018 • Age: 8 yrs
Small-molecule therapeutics for immune diseases are developed using protein structures.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 11 Brand Intelligence

About S-Curis

S-Curis is a company based in Sejong City (South Korea) founded in 2018. S-Curis offers products and services including Website Samples and Adult Verification Service. S-Curis operates in a competitive market with competitors including Biogen, Incyte, ADMA Biologics, Kymeratx and LEO Pharma, among others.

  • Headquarter Sejong City, South Korea
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of S-Curis

S-Curis offers a comprehensive portfolio of products and services, including Website Samples and Adult Verification Service.

Product name locked
Category locked
Primary

Provides templates for secure online sites with verification.

Product name locked
Category locked
Locked

Offers age confirmation for restricted content access.

Funding Insights of S-Curis

Premium access

Detailed funding history for S-Curis

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by S-Curis

Investments
Premium access

Investment portfolio details for S-Curis

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - S-Curis

Premium access

Detailed financials for S-Curis

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

S-Curis Comparisons

S-Curis Primary company
Description
Small-molecule therapeutics for immune diseases are develope...
Location
Sejong City, South Korea
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for S-Curis

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of S-Curis

S-Curis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, Incyte, ADMA Biologics, Kymeratx and LEO Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapies for neurodegenerative and immunology disorders are developed.
Locked Locked Locked
Small molecules are developed for cancer and skin disease treatments.
Locked Locked Locked
Plasma-based biologics are developed for immune deficiency and infectious diseases.
Locked Locked Locked
Small molecule protein degraders are developed for various disorders.
Locked Locked Locked
Developer of drugs for treating dermatology diseases
Locked Locked Locked
Immunotherapeutics for cancer and other diseases are developed.
Premium access

Detailed competitors of S-Curis

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on S-Curis

Premium access

Complete news archive for S-Curis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about S-Curis

S-Curis was founded in 2018.

S-Curis is headquartered in Sejong City, South Korea.

Jeon Young ho is the current CEO of S-Curis.

Founded in 2018 and based in Sejong City, South Korea, small-molecule drugs are developed by S-Curis targeting immune-related conditions. These drugs rely on three-dimensional protein structures linked to cytokine signal transduction pathways. A development pipeline is focused on asthma, atopic dermatitis, and allergic rhinitis within the biotechnology sector. Operations emphasize therapeutic innovation for immunology applications.

S-Curis's top competitors include ADMA Biologics, BioNTech and LEO Pharma.

S-Curis offers Website Samples and Adult Verification Service.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available